EPHA2 and renal cell carcinoma: Herrem et al. investigated the protein expression of EPHA2 in a small RCC cohort with mixed histological subtypes including 30 ccRCC and four non-ccRCC, whereupon EPHA2 protein levels inversely correlated with progression-free interval and overall survival period [22].